Tissue adhesive therapy for corneal perforations.

The current indications for and method of application of tissue adhesive are described. A method for an expanded utilisation of tissue adhesive is discussed. To study the effect of the introduction of tissue adhesive to The Wilmer Institute in 1974, the records of 104 consecutive non-traumatic corneal perforations or descemetoceles admitted to The Wilmer Institute from 1960 to 1980 were assessed retrospectively with follow-up being obtained from records or from referral physicians for 87 of these perforations. Forty-nine percent of the cases were caused by bacterial corneal ulcers, 13% by exposure, 12% by chemical burns, 6% by fungal keratitis, 5% by herpes simplex keratitis, and 15% were undiagnosed. Since the introduction of tissue adhesive in 1974, there has been an apparent trend towards a lower enucleation rate (6%) in the tissue adhesive treated group compared with 19% in perforations treated by other therapies.
AuthorsL W Hirst, W E Smiddy, E De Juan
JournalAustralian journal of ophthalmology (Aust J Ophthalmol) Vol. 11 Issue 2 Pg. 113-8 (May 1983) ISSN: 0310-1177 [Print] AUSTRALIA
PMID6870685 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cyanoacrylates
  • Bucrylate
  • Adolescent
  • Adult
  • Aged
  • Bucrylate (therapeutic use)
  • Child
  • Child, Preschool
  • Corneal Diseases (etiology, therapy)
  • Corneal Ulcer (complications)
  • Cyanoacrylates (therapeutic use)
  • Descemet Membrane
  • Follow-Up Studies
  • Hernia (therapy)
  • Humans
  • Infant
  • Middle Aged
  • Ophthalmologic Surgical Procedures
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: